Advanced search
Publication Cover
Cytotherapy Volume 13, 2011 - Issue 8
Journal homepage
129
Views
3
CrossRef citations to date
0
Altmetric
Original Papers

Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells

Han DongmeiDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Liu JingDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Xue MeiDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Zhu LingDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Yan HongminDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Wang ZhidongDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Ding LiDepartment of Hematology, General Hospital of the Air Force, Beijing, China
,
Guo ZikuanDepartment of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing, China
&
Wang HengxiangDepartment of Hematology, General Hospital of the Air Force, Beijing, ChinaCorrespondence[email protected]
 show all
Pages 913-917 | Received 21 Nov 2010, Accepted 31 Mar 2011, Published online: 05 May 2011

References

  • Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93–103.
  • Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, . Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica. 2009; 94:1649–60.
  • Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568–84.
  • Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, . Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94–8.
  • Huang HY. Prosthetics of central nervous system. Peking Science Publishing Co. Peking. 2009;4:479–82.
  • Lawton and Brody. Activity of daily living scale (ADL). Chinese J Min Inv Neurosurg. 2006;11:516–516.
  • Alison MR, Poulsom R, Forbes S, Wright NA. An introduction of stem cells. J Path. 2002;197:419–23.
  • Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, . Immunogenicity of umbilical cord tissue derived cells. Blood. 2008;111:430–8.
  • Satake K, Lou J, Lenke LG. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine Phila Pa. 1976. 2004;29:1971–9.
  • Meirelles LS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–13.
  • Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, . Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24:781–92.
  • Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmamacol Ther. 2008;83:723–30.
  • Burns JS, Abdallah BM, Schrøder HD, Kassem M. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma? Histol Histopathol. 2008;23:1229–40.
  • Rubio D, Garcia S, Paz MF, De la Cueva T, Lopez-Fernandez LA, Lloyd AC, . Molecular characterization of spontaneous mesenchymal stem cell transformation. PloS One. 2003;3:e1398–1398.
  • Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ, . Enhancement of neuroplasticity through upregulation of betal-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis. 2007; 27:339–53.
  • Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, . Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 2008; 1229:223–48.
  • Kan I, Melamed E, Offen D. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Hand Exp Pharmacol. 2007;180:219–42.
  • Lee PH, Park HJ. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J Clin Neurol. 2009;5:1–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.